You are here: News & Events > Research News > Research News

Research News

News Feed (What is RSS or Atom?)
30 Aug 2016
Researchers have found a simple way to boost the efficiency of the ground-breaking gene-editing technology CRISPR-Cas9 by up to five times. CRISPR-Cas9 is a technique for knocking out genes in human cell lines to discover what the genes do but the efficiency with which it disables genes can vary immensely.
01 Aug 2016
ReNeuron Group plc, a UK-based stem cell research company, has announced further key pre-clinical efficacy data with its human retinal progenitor cells (hRPCs). A Phase I/II clinical trial has recently commenced in the US to evaluate the safety, tolerability and preliminary efficacy of the hRPCs in patients with RP.
29 Jul 2016
Argus II study results published in Ophthalmology show safety and sustained improvement in visual performance for blind patients.
27 Jul 2016
The first results of an in-human stem cell transplant to treat retinitis pigmentosa have been released by regenerative medicine company jCyte.
21 Jun 2016
RP Fighting Blindness has been asked to share trials information regarding the Oxford University trial of a sub retinal electronic implant (Alpha AMS, Retina Implant AG, Germany).
21 Jun 2016
RP Fighting Blindness has been asked to share trials information regarding the Oxford University trial of a sub retinal electronic implant (Alpha AMS, Retina Implant AG, Germany).
09 Jun 2016
A Moorfields Eye Hospital surgeon believes that the technology now exists to replace the eye’s degenerated photoreceptors with a new, modifiable bionic eye.
26 May 2016
A trio of eyeglasses using revolutionary prism techniques could open up a whole new field of view for patients with hemianopia and tunnel vision.
28 Apr 2016
Pioneering gene therapy has restored some vision to patients with choroideremia, raising hopes it could be used to cure common causes of vision loss, new University of Oxford research published today shows.
11 Apr 2016
Acucela Inc, of Seattle, has licenced the gene therapy developed by the University of Manchester. Acucela announced its plans to develop and commercialise the technology targeting the condition with the university.

Archived Articles



donate to us with CAF
 

RP Online

RP on Facebook The RP blog Follow RPdch on Twitter